| Gene symbol | tk |
| GTO ID | GTC1121 |
| Trial ID | JPRN-UMIN000002502 |
| Disease | Hematologic Cancer |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | HSV-TK transduced T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Add-back therapy with HSV-TK gene transduced donor lymphocytes after T-cell-depleted haplo-identical hematopoietic stem cell transplantation |
| Year | 2009 |
| Country | Japan |
| Company sponsor | National Cancer Institute (NCI) |
| Cohort 1 | |||||||
|
|||||||